MSR, PATH announce launch of new water treatment product

NewsGuard 100/100 Score

Local outdoor gear manufacturer MSR (Mountain Safety Research®) and Seattle-based international nonprofit organization and global health innovation leader PATH today announced the launch of a new water treatment product, the result of a five-year partnership to bring low-cost community water solutions to the global market. The MSR SE200© Community Chlorine Maker is a portable device that can produce enough chlorine to treat up to 200 liters of safe drinking water in low resource and disaster stricken communities in just five minutes with the push of a button. The two organizations commemorated the launch at an event held at MSR's manufacturing plant in the SODO neighborhood near downtown Seattle, where the device will be made.

More than 700 million people lack access to quality sources of drinking water, and unsafe water conditions contribute to diarrheal disease, one of the leading causes of preventable childhood deaths in developing countries. Chlorine is an effective method for destroying pathogenic microorganisms and has been shown to reduce the threat of waterborne disease. However, many people living in urban slums and rural villages have limited access to chlorine due to cost and unreliable supply. Using only salt, water, and a power source (via local power sources or a 12 volt battery), the MSR SE200 produces a consistent concentration of chlorine solution on demand that can be used to treat water at wells, water kiosks, water trucks, in schools, and other common sources of community water.

The SE200 is the first product from the newly-created MSR Global Health division, dedicated to improving access to innovative technologies for people living on less than $5 per day.

"Over five years ago PATH saw that we were engineering water treatment products for the military and outdoor recreation market, and partnered with us to co-design these technologies into products that can make a sustainable difference in global health," said Joe McSwiney, president of Cascade Designs, the parent company of MSR. "What happened next was the birth of a very unique relationship between a Seattle manufacturer and a local Seattle nonprofit that, together, working on sustainable commercial models, are overcoming many of the barriers to technology adoption by people who live in low-resource settings. The MSR SE200 Chlorine Maker is just the beginning of what we have planned, and we look forward to fostering our Seattle partnerships to continue developing products that save lives."

"PATH has nearly 40 years of experience mobilizing cross-sector partnerships to transform innovative ideas into health solutions for people living in low-income countries," said Glenn Austin, senior advisor of product development at PATH. "Through comprehensive research, numerous field studies, and user-centered design and development, this partnership was able to deliver a product that is affordable and easy to use and maintain in many different settings. Our ongoing work to advance safe water interventions brings us close to people living in communities around the world and it has been terrific to see their satisfaction in finally having a reliable tool to create safe drinking water."

The MSR SE200 Community Chlorine Maker--co-designed by MSR and PATH--was made possible with assistance from other Seattle-based nonprofits including Christian humanitarian organization World Vision and the Washington Global Health Alliance. Through the Life Science Discovery Fund, World Vision will be introducing the first 150 MSR SE200 Community Chlorine Maker products off the factory line in both East and West African communities.

"We are grateful to our partners at MSR and PATH for their shared commitment to ensure that everyone has clean and safe water," said Greg Allgood, vice president of water at World Vision.

Source:

PATH

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New research sheds light on how GLP-1 obesity drugs may change food cravings